Director, Medical Affairs Training
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Director, Medical Affairs Training supporting Global Medical Affairs to build and lead the training strategy preparing field and office-based medical teams to be scientifically rigorous, operationally fluent, and compliant. You will shape and implement the Medical Affairs training strategy and roadmap, from onboarding through certification and continuous development.
Job description
Build our future together
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Director, Medical Affairs Training supporting Global Medical Affairs to build and lead the training strategy preparing field and office-based medical teams to be scientifically rigorous, operationally fluent, and compliant. You will shape and implement the Medical Affairs training strategy and roadmap, from onboarding through certification and continuous development.
When & where
- Location: US
- Work model/flexibility: Remote
- Travel percentage: Up to 20%
Discover your role
- Partner with subject matter experts, who own the scientific content turning business needs into tailored capability solutions
- Apply adult-learning principles and instructional design models (e.g., ADDIE, SAM) to create engaging live, virtual, and digital training
- Deliver onboarding that prepares new field medical hires for confident, scientifically credible deployment
- Teach complex medical and scientific concepts and keep teams current on emerging clinical data and disease-state advances
- Identify skill gaps with field medical leadership, and join field rides and HCP engagements
- Guide training and external communication materials through medical review, and manage vendors, budgets, and content development
- Define KPIs and training analytics that measure proficiency, on-the-job application, and business impact
- Travel include locally and regionally, with overnight stays for KOL meetings, site visits, medical meetings, and congresses
This role requires
- Advanced medical or scientific degree (e.g., MD/DO, PharmD, PhD, NP, PA, or equivalent); doctorate-level training preferred
- 10+ years in Medical Affairs or a relevant area, including 5+ years leading global capability-building or medical training programs and/or Medical Affairs leadership
- Deep understanding of adult learning, organizational development, change management, and instructional design
- Field medical experience (MSL / Health Outcomes Liaison) is preferred
- Product-launch experience and prior development of educational assets (slide decks, FAQs, MSL materials)
- Proficiency with Microsoft Office, Veeva, learning management systems, and virtual training platforms
Requirements
- Advanced medical or scientific degree (e.g., MD/DO, PharmD, PhD, NP, PA, or equivalent)
- 10+ years in Medical Affairs or a relevant area
- 5+ years leading global capability-building or medical training programs and/or Medical Affairs leadership
- Deep understanding of adult learning, organizational development, change management, and instructional design
- Product-launch experience and prior development of educational assets (slide decks, FAQs, MSL materials)
- Proficiency with Microsoft Office, Veeva, learning management systems, and virtual training platforms
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.